A tale of the two PEGylated liposomal doxorubicins

  • Jacqueline Liu, Hung-Hsueh Chou, Hao Lin
  • OncoTargets and Therapy, July 2015, Dove Medical Press
  • DOI: 10.2147/ott.s79089

pegylated liposomal doxorubicin generics?

What is it about?

Lipid composition of liposomes that carry chemotherapeutic agents can differ a great deal, with resulting differences in pharmacokinetics, and many other parameters. However, when similar names are chosen, confusion ensues.

open access logoRead Publication

http://dx.doi.org/10.2147/ott.s79089

The following have contributed to this page: Dr Jacqueline M Liu